Testing a new drug for sepsis-related lung injury
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new medicine called YD0743 for people who have both sepsis (a serious infection) and ARDS (a severe lung injury from the infection). The goal is to see if the medicine helps improve breathing and survival.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have sepsis and a lung condition called ARDS that is likely caused by the sepsis.
- Your ARDS diagnosis was made within the last 48 hours.
- You are not on a life-support machine called ECMO for your lungs.
- You do not have a known bleeding disorder, low platelet count, or active bleeding.
- You are not pregnant or breastfeeding, and do not plan to become pregnant in the next 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patients with sepsis (a severe infection that affects organs) and acute respiratory distress syndrome (ARDS, a serious lung condition) to learn more about these illnesses and improve care.
This study looks at the early changes in the lungs of people with sepsis who develop a severe breathing problem called ARDS. Researchers will collect small samples of lung fluid to better understand the condition and potentially improve future treatments.
This trial tests a new treatment to protect and repair the layer of cells lining your blood vessels (glycocalyx) during sepsis. It aims to improve recovery from severe infections.
This trial tests whether a quick genetic test can help doctors choose the right treatment for patients with a suspected severe infection (sepsis) more quickly. The goal is to improve recovery by personalizing care based on your body's response.
This trial tests if a new drug, AZD4144, can help people with sepsis-related acute kidney injury in the ICU. It aims to see if the drug can improve kidney recovery and reduce complications.
This trial studies a quick set of tests to figure out whether a person with severe infection (sepsis) will respond to corticosteroids like hydrocortisone. The goal is to guide treatment sooner and avoid ineffective care.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.